Scientists target new biomarkers for Alzheimer's, immune system health and colon cancer;

> UT Southwestern Medical Center scientists have helped develop a novel technology to diagnose Alzheimer's disease from blood samples long before symptoms appear. This preliminary technology, which uses synthetic molecules to seek out and identify disease-specific antibodies, also could be used eventually in the development of specific biomarkers for a range of other hard-to-diagnose diseases and conditions, including Parkinson's disease and immune system-related diseases like multiple sclerosis and lupus, the researchers predict. Release

> Investigators at Stanford have set out to find a common biomarker that can be used to assess the health of the human immune system. Story

> Micromedic Technologies is engaged in a clinical trial designed to find biomarkers for early-stage colon cancer. Report

> A new Indo-US Cancer Prevention and Biomarker workshop has been inaugurated to help target drugs where they will be most effective. Story

> Luminex Corporation has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.  Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.